Zhejiang Ausun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Ausun Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥27.68 Million (capex CN¥27.68 Million ) from operating cash flow of CN¥121.49 Million. Explore cash flow to debt ratio of Zhejiang Ausun Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Ausun Pharmaceutical Co Ltd (2013–2025)
Cash flow reinvestment rate of Zhejiang Ausun Pharmaceutical Co Ltd from 2013 to 2025. Historical reinvestment intensity for Zhejiang Ausun Pharmaceutical Co Ltd across 13 annual periods. Explore Zhejiang Ausun Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Ausun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2013–2025)
Zhejiang Ausun Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Ausun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Ausun Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | CN¥104.45 Million | CN¥156.51 Million | CN¥104.45 Million | ▲ +4.6% |
| 2024 | 0.64x | CN¥113.55 Million | CN¥177.93 Million | CN¥111.30 Million | ▼ -58.2% |
| 2023 | 1.53x | CN¥338.94 Million | CN¥221.85 Million | CN¥163.47 Million | ▼ -36.4% |
| 2022 | 2.40x | CN¥289.41 Million | CN¥120.57 Million | CN¥271.91 Million | ▼ -1.9% |
| 2021 | 2.45x | CN¥425.57 Million | CN¥173.90 Million | CN¥310.85 Million | ▲ +220.7% |
| 2020 | 0.76x | CN¥105.67 Million | CN¥138.47 Million | CN¥92.95 Million | ▼ -29.9% |
| 2019 | 1.09x | CN¥95.46 Million | CN¥87.73 Million | CN¥49.63 Million | ▼ -83.0% |
| 2018 | 6.41x | CN¥73.73 Million | CN¥11.50 Million | CN¥55.05 Million | ▲ +162.2% |
| 2017 | 2.44x | CN¥114.36 Million | CN¥46.78 Million | CN¥54.36 Million | ▲ +121.7% |
| 2016 | 1.10x | CN¥102.79 Million | CN¥93.21 Million | CN¥42.79 Million | ▲ +38.2% |
| 2015 | 0.80x | CN¥42.80 Million | CN¥53.63 Million | CN¥42.80 Million | ▼ -25.8% |
| 2014 | 1.08x | CN¥23.08 Million | CN¥21.45 Million | CN¥23.08 Million | ▼ -53.9% |
| 2013 | 2.33x | CN¥36.71 Million | CN¥15.73 Million | CN¥36.71 Million | — |